227 related articles for article (PubMed ID: 29145032)
1. Intravenous immunoglobulin improves glucose control and β-cell function in human IAPP transgenic mice by attenuating islet inflammation and reducing IAPP oligomers.
Zhang Y; Yu XL; Zhu J; Liu SY; Liu XM; Dong QX; Chai JQ; Liu RT
Int Immunopharmacol; 2018 Jan; 54():145-152. PubMed ID: 29145032
[TBL] [Abstract][Full Text] [Related]
2. Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced beta-cell apoptosis in h-IAPP transgenic mice.
Lin CY; Gurlo T; Kayed R; Butler AE; Haataja L; Glabe CG; Butler PC
Diabetes; 2007 May; 56(5):1324-32. PubMed ID: 17353506
[TBL] [Abstract][Full Text] [Related]
3. Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction.
Rodríguez-Comas J; Moreno-Vedia J; Obach M; Castaño C; de Pablo S; Alcarraz-Vizán G; Díaz-Catalán D; Mestre A; Horrillo R; Costa M; Novials A; Servitja JM
Mol Metab; 2020 Jul; 37():100984. PubMed ID: 32229246
[TBL] [Abstract][Full Text] [Related]
4. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus.
Jeong HR; An SS
Clin Interv Aging; 2015; 10():1873-9. PubMed ID: 26604727
[TBL] [Abstract][Full Text] [Related]
5. Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes.
Matveyenko AV; Butler PC
ILAR J; 2006; 47(3):225-33. PubMed ID: 16804197
[TBL] [Abstract][Full Text] [Related]
6. Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets.
Aston-Mourney K; Hull RL; Zraika S; Udayasankar J; Subramanian SL; Kahn SE
Diabetologia; 2011 Jul; 54(7):1756-65. PubMed ID: 21484213
[TBL] [Abstract][Full Text] [Related]
7. Autophagy defends pancreatic β cells from human islet amyloid polypeptide-induced toxicity.
Rivera JF; Costes S; Gurlo T; Glabe CG; Butler PC
J Clin Invest; 2014 Aug; 124(8):3489-500. PubMed ID: 25036708
[TBL] [Abstract][Full Text] [Related]
8. IAPP-induced beta cell stress recapitulates the islet transcriptome in type 2 diabetes.
Blencowe M; Furterer A; Wang Q; Gao F; Rosenberger M; Pei L; Nomoto H; Mawla AM; Huising MO; Coppola G; Yang X; Butler PC; Gurlo T
Diabetologia; 2022 Jan; 65(1):173-187. PubMed ID: 34554282
[TBL] [Abstract][Full Text] [Related]
9. BRICHOS domain of Bri2 inhibits islet amyloid polypeptide (IAPP) fibril formation and toxicity in human beta cells.
Oskarsson ME; Hermansson E; Wang Y; Welsh N; Presto J; Johansson J; Westermark GT
Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2752-E2761. PubMed ID: 29507232
[TBL] [Abstract][Full Text] [Related]
10. RAGE binds preamyloid IAPP intermediates and mediates pancreatic β cell proteotoxicity.
Abedini A; Cao P; Plesner A; Zhang J; He M; Derk J; Patil SA; Rosario R; Lonier J; Song F; Koh H; Li H; Raleigh DP; Schmidt AM
J Clin Invest; 2018 Feb; 128(2):682-698. PubMed ID: 29337308
[TBL] [Abstract][Full Text] [Related]
11. Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway.
Gurlo T; Ryazantsev S; Huang CJ; Yeh MW; Reber HA; Hines OJ; O'Brien TD; Glabe CG; Butler PC
Am J Pathol; 2010 Feb; 176(2):861-9. PubMed ID: 20042670
[TBL] [Abstract][Full Text] [Related]
12. IL-1 mediates amyloid-associated islet dysfunction and inflammation in human islet amyloid polypeptide transgenic mice.
Westwell-Roper CY; Chehroudi CA; Denroche HC; Courtade JA; Ehses JA; Verchere CB
Diabetologia; 2015 Mar; 58(3):575-85. PubMed ID: 25491100
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide.
Janson J; Soeller WC; Roche PC; Nelson RT; Torchia AJ; Kreutter DK; Butler PC
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7283-8. PubMed ID: 8692984
[TBL] [Abstract][Full Text] [Related]
14. Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3'-kinase-dependent pathway.
Lin CY; Gurlo T; Haataja L; Hsueh WA; Butler PC
J Clin Endocrinol Metab; 2005 Dec; 90(12):6678-86. PubMed ID: 16204373
[TBL] [Abstract][Full Text] [Related]
15. Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics.
Abedini A; Plesner A; Cao P; Ridgway Z; Zhang J; Tu LH; Middleton CT; Chao B; Sartori DJ; Meng F; Wang H; Wong AG; Zanni MT; Verchere CB; Raleigh DP; Schmidt AM
Elife; 2016 May; 5():. PubMed ID: 27213520
[TBL] [Abstract][Full Text] [Related]
16. Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1β production and β-cell dysfunction.
Westwell-Roper CY; Ehses JA; Verchere CB
Diabetes; 2014 May; 63(5):1698-711. PubMed ID: 24222351
[TBL] [Abstract][Full Text] [Related]
17. Islet amyloid inhibitors improve glucose homeostasis in a transgenic mouse model of type 2 diabetes.
Wijesekara N; Ahrens R; Wu L; Ha K; Liu Y; Wheeler MB; Fraser PE
Diabetes Obes Metab; 2015 Oct; 17(10):1003-6. PubMed ID: 26095311
[TBL] [Abstract][Full Text] [Related]
18. Islet amyloid polypeptide in pancreatic islets from type 2 diabetic subjects.
Tomita T
Islets; 2012; 4(3):223-32. PubMed ID: 22847497
[TBL] [Abstract][Full Text] [Related]
19. The β-cell assassin: IAPP cytotoxicity.
Raleigh D; Zhang X; Hastoy B; Clark A
J Mol Endocrinol; 2017 Oct; 59(3):R121-R140. PubMed ID: 28811318
[TBL] [Abstract][Full Text] [Related]
20. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
Westermark P; Andersson A; Westermark GT
Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
